SCAMP3

SCAMP3 is a multi-spanning transmembrane protein of the trans-Golgi network and post-Golgi endosomal membranes that governs the sorting decision between recycling and lysosomal degradation of the EGF receptor (PMID:19158374, PMID:19438519). Activated EGFR co-immunoprecipitates with SCAMP3 and directly phosphorylates it on tyrosine, with Y86 identified as the functional site; phospho-Y86 strengthens the SCAMP3–EGFR interaction and is required for SCAMP3 to drive EGFR degradation and attenuate downstream MAP kinase signaling (PMID:9658162, PMID:33850265). SCAMP3 couples to the ESCRT machinery, associating with the Nedd4 HECT ubiquitin ligases through its PY motif, with ESCRT-I subunit Tsg101 through its PSAP motif, and with ESCRT-0 subunit Hrs, and is itself multimonoubiquitylated; these interactions tune EGFR recycling from early endosomes against its sorting into intralumenal vesicles of multivesicular bodies and onward delivery to lysosomes (PMID:19158374, PMID:21951651). In cancer cells SCAMP3 redistributes EGFR to the perinuclear region and cooperates with EPS8 to maintain EGFR stability, with its loss reducing EGFR degradation yet attenuating AKT, ERK, and STAT3 output and disrupting mTORC1 signaling and autophagic flux (PMID:35681787, PMID:41096842, PMID:41151858). Beyond EGFR trafficking, SCAMP3 is required for regulated secretory and granule biology: it is needed for neutrophil granule formation, content, and degranulation (PMID:41187789), associates with insulin secretory granules to control insulin content and secretion in β-cells (PMID:39320956), and acts as an anti-adipogenic factor downstream of PPARG (PMID:31554889).

1. 1998 High

   Established the first molecular link between SCAMP3 and a signaling receptor by showing it is an EGF-responsive phosphoprotein and a direct EGFR substrate, defining EGFR as its upstream kinase.

   Evidence Co-IP, in vitro kinase assay with recombinant EGFR, and vanadate/PTP1B phosphorylation assays

   PMID:9658162

   Open questions at the time

   • Did not map the phosphorylated tyrosine residue
   • Functional consequence of phosphorylation for trafficking not established
2. 2009 High

   Defined how SCAMP3 mechanistically engages the endosomal sorting machinery, showing it links Nedd4 ligases and ESCRT components to bias EGFR toward recycling over degradation.

   Evidence Reciprocal co-IP, PY/PSAP/lysine mutants, RNAi depletion with dual-depletion epistasis, and immuno-EM of EGFR-containing MVBs

   PMID:19158374

   Open questions at the time

   • The specific Nedd4 family member acting in vivo not resolved
   • Did not establish which ubiquitylated lysines are functionally critical
3. 2009 Medium

   Localized SCAMP3 to the trans-Golgi network and implicated it in post-Golgi trafficking dynamics by showing it maintains Salmonella-containing vacuoles.

   Evidence siRNA screen and fluorescence colocalization in Salmonella-infected HeLa cells

   PMID:19438519

   Open questions at the time

   • Mechanism of SCAMP3 contribution to vacuole maintenance unknown
   • Relationship between TGN pool and endosomal EGFR-sorting pool not defined
4. 2011 Medium

   Resolved an apparent paradox by showing SCAMP3 also positively promotes MVB/ILV biogenesis and EGFR sorting into MVBs, indicating it acts at multiple steps of the degradative pathway.

   Evidence Cell-free MVB biogenesis assay and SCAMP3 depletion with ILV-formation readout

   PMID:21951651

   Open questions at the time

   • Molecular determinants on SCAMP3 driving ILV formation not mapped
   • Single-lab in vitro assay
5. 2021 High

   Identified Y86 as the functional phosphosite and tied it causally to EGFR degradation and signaling attenuation, converting the 1998 phosphorylation observation into a defined regulatory mechanism with tumor relevance.

   Evidence Phosphoproteomics, Y86F mutagenesis with knockdown rescue, EGFR degradation assays, and xenograft growth

   PMID:33850265

   Open questions at the time

   • Structural basis for how phospho-Y86 strengthens EGFR binding unknown
   • Phosphatase that reverses Y86 in cells not identified
6. 2022 Medium

   Confirmed in a cancer-cell context that SCAMP3 controls EGFR subcellular distribution and degradation and shapes AKT/ERK/STAT3 output.

   Evidence EGFR internalization/colocalization assays and CRISPR knockout with signaling readouts and xenograft models in TNBC

   PMID:35681787

   Open questions at the time

   • Reconciliation of reduced degradation with attenuated signaling not fully mechanistic
   • Single lab
7. 2024 Medium

   Extended SCAMP3 function beyond EGFR trafficking to regulated secretion, establishing it as an insulin secretory granule protein required for normal insulin content and secretion.

   Evidence ISG proteomics, confocal colocalization in β-cells, and siRNA knockdown with insulin content/secretion assays

   PMID:39320956

   Open questions at the time

   • Molecular mechanism by which SCAMP3 affects granule content unknown
   • ESCRT/EGFR machinery relevance to ISG biology untested
8. 2025 High

   Demonstrated a broad requirement for SCAMP3 in granule biogenesis across cell types by showing it is essential for neutrophil granule formation, content, and antimicrobial degranulation.

   Evidence Scamp3 knockout in Hoxb8-derived neutrophils and zebrafish with proteomics and bacterial killing/degranulation assays

   PMID:41187789

   Open questions at the time

   • Whether the same trafficking machinery used for EGFR operates in granule biogenesis untested
   • Direct cargo or sorting partners in neutrophils not identified
9. 2025 Medium

   Provided a lipid-transfer mechanism for SCAMP3 in ILV/exosome biogenesis, showing it recruits BLTP2 to ER–MVB contact sites in a Rab5-dependent, NEDD4-regulated manner.

   Evidence Co-IP, BLTP2/SCAMP3 depletion, endosomal lipidomics, Rab5 dependency, and NEDD4 ubiquitination assays (preprint)

   PMID:bio_10.1101_2025.04.17.649455

   Open questions at the time

   • Preprint, not peer-reviewed; single lab
   • Direct contact-site topology of SCAMP3–BLTP2 not structurally defined
10. 2025 Medium

    Broadened the cancer signaling role by showing SCAMP3 coordinates residual ERK activity, mTORC1 signaling, and autophagic flux, and cooperates with EPS8 to stabilize EGFR.

    Evidence TMT phosphoproteomics in SCAMP3 KO TNBC cells under inhibitor conditions and co-IP/knockdown/overexpression with EPS8 and AR-V7

    PMID:41096842 PMID:41151858

    Open questions at the time

    • Direct vs indirect effects on ERK feedback regulators not separated
    • Whether EPS8 interaction is direct not established

• It remains unresolved how SCAMP3's transmembrane topology and motif-based interactions are mechanistically shared across its distinct roles in EGFR sorting, ILV/exosome biogenesis, and regulated granule secretion.
• No structural model of SCAMP3 in any membrane context
• Unknown whether ESCRT/Nedd4 engagement applies to insulin and neutrophil granule biology
• Native stoichiometry of SCAMP3–EGFR–ESCRT assemblies undefined